Kiso Ji is a leading next-generation antibody company discovering and developing highly differentiated antibody therapeutics to address difficult targets in oncology and other diseases
Kiso Ji is a leading next-generation antibody company discovering and developing highly differentiated antibody therapeutics to address difficult targets in oncology and other diseases. Our antibody platform enables the visualization of the complete immune response of an animal, allowing unprecedented direct control over antibody sampling for therapeutic, diagnostic, and vaccine development.